Polymorphisms in TLR-2 are associated with congenital cytomegalovirus (CMV) infection but not with congenital CMV disease

International Journal of Infectious Diseases

Volumn 17, Issue 12, 2013, Pages

  Taniguchi, Rumi ^a,b   Koyano, Shin ^c   Suzutani, Tatsuo ^d   Goishi, Keiji ^b   Ito, Yushi ^e   Morioka, Ichiro ^f   Oka, Akira ^b,g   Nakamura, Hiroyuki ^e   Yamada, Hideto ^f   Igarashi, Takashi ^b   Inoue, Naoki ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^e NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^f KOBE UNIVERSITY   (Japan)

^g KYORIN UNIVERSITY   (Japan)

Author keywords

Congenital infection; Cytomegalovirus; Polymorphisms; Toll like receptors

Indexed keywords

TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

CHILD; CONGENITAL INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MODEL; GENOTYPE; HUMAN; INFANT; JAPANESE; MAJOR CLINICAL STUDY; POPULATION GENETICS; PRESCHOOL CHILD; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM;

CONGENITAL INFECTION; CYTOMEGALOVIRUS; POLYMORPHISMS; TOLL-LIKE RECEPTORS;

ALLELES; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 2;

EID: 84888432113     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2013.06.004     Document Type: Short Survey

References (35)

1. Cannon M.J. Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Virol 2009, 46(Suppl 4):S6-S10.
2. Kenneson A., Cannon M.J. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007, 17:253-276.
3. Revello M.G., Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002, 15:680-715.
4. Koyano S., Inoue N., Oka A., Moriuchi H. Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper: feasibility and outcomes from a multicentre study. BMJ Open 2011, 2011:e000118.
5. Yan H., Koyano S., Inami Y., Yamamoto Y., Suzutani T., Mizuguchi M., et al. Genetic variations in the gB, UL144 and UL149 genes of human cytomegalovirus strains collected from congenitally and postnatally infected Japanese children. Arch Virol 2008, 153:667-674.
6. Ross S.A., Novak Z., Fowler K.B., Arora N., Britt W.J., Boppana S.B. Cytomegalovirus blood viral load and hearing loss in young children with congenital infection. Pediatr Infect Dis J 2009, 28:588-592.
7. Pignatelli S., Dal Monte P., Rossini G., Landini M.P. Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev Med Virol 2004, 14:383-410.
8. Munro S.C., Hall B., Whybin L.R., Leader L., Robertson P., Maine G.T., Rawlinson W.D. Diagnosis of and screening for cytomegalovirus infection in pregnant women. J Clin Microbiol 2005, 43:4713-4718.
9. Pedron B., Guerin V., Jacquemard F., Munier A., Daffos F., Thulliez P., et al. Comparison of CD8+ T cell responses to cytomegalovirus between human fetuses and their transmitter mothers. J Infect Dis 2007, 196:1033-1043.
10. Nozawa N., Fang-Hoover J., Tabata T., Maidji E., Pereira L. Cytomegalovirus-specific, high-avidity IgG with neutralizing activity in maternal circulation enriched in the fetal bloodstream. J Clin Virol 2009, 46(Suppl 4):S58-S63.
11. Szala A., Paradowska E., Nowakowska D., Swierzko A.S., Dzierzanowska-Fangrat K., Sokolowska A., et al. Mannan-binding lectin-2 (MBL2) gene polymorphisms in prenatal and perinatal cytomegalovirus infections. Mol Immunol 2011, 48:2203-2206.
12. Marchant A., Appay V., Van Der S.M., Dulphy N., Liesnard C., Kidd M., et al. Mature CD8(+) T lymphocyte response to viral infection during fetal life. J Clin Invest 2003, 111:1747-1755.
13. Schroder N.W., Schumann R.R. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 2005, 5:156-164.
14. Kijpittayarit S., Eid A.J., Brown R.A., Paya C.V., Razonable R.R. Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Clin Infect Dis 2007, 44:1315-1320.
15. Ducloux D., Deschamps M., Yannaraki M., Ferrand C., Bamoulid J., Saas P., et al. Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int 2005, 67:2454-2461.
16. Carvalho A., Cunha C., Carotti A., Aloisi T., Guarrera O., Di Ianni M., et al. Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation. Exp Hematol 2009, 37:1022-1029.
17. Boehme K.W., Guerrero M., Compton T. Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J Immunol 2006, 177:7094-7102.
18. Compton T., Kurt-Jones E.A., Boehme K.W., Belko J., Latz E., Golenbock D.T., Finberg R.W. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 2003, 77:4588-4596.
19. Lore K., Betts M.R., Brenchley J.M., Kuruppu J., Khojasteh S., Perfetto S., et al. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses. J Immunol 2003, 171:4320-4328.
20. Bozza S., Gaziano R., Bonifazi P., Zelante T., Pitzurra L., Montagnoli C., et al. Thymosin alpha1 activates the TLR9/MyD88/IRF7-dependent murine cytomegalovirus sensing for induction of anti-viral responses in vivo. Int Immunol 2007, 19:1261-1270.
21. Tabeta K., Georgel P., Janssen E., Du X., Hoebe K., Crozat K., et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci U S A 2004, 101:3516-3521.
22. Ogawa H., Suzutani T., Baba Y., Koyano S., Nozawa N., Ishibashi K., et al. Etiology of severe sensorineural hearing loss in children: independent impact of congenital cytomegalovirus infection and GJB2 mutations. J Infect Dis 2007, 195:782-788.
23. Inoue N., Koyano S. Evaluation of screening tests for congenital cytomegalovirus infection. Pediatr Infect Dis J 2008, 27:182-184.
24. Chen J., Liang Z., Lu F., Fang X., Liu S., Zeng Y., et al. Toll-like receptors and cytokines/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine. Vaccine 2011, 29:706-711.
25. Ovsyannikova I.G., Haralambieva I.H., Vierkant R.A., Pankratz V.S., Jacobson R.M., Poland G.A. The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity. Hum Genet 2011, 130:547-561.
26. Bochud P.Y., Magaret A.S., Koelle D.M., Aderem A., Wald A. Polymorphisms in TLR2 are associated with increased viral shedding and lesional rate in patients with genital herpes simplex virus type 2 infection. J Infect Dis 2007, 196:505-509.
27. Zhou L., Wei B., Xing C., Xie H., Yu X., Wu L., Zheng S. Polymorphism in 3'-untranslated region of toll-like receptor 4 gene is associated with protection from hepatitis B virus recurrence after liver transplantation. Transpl Infect Dis 2011, 13:250-258.
28. Ricci E., Malacrida S., Zanchetta M., Mosconi I., Montagna M., Giaquinto C., De Rossi A. Toll-like receptor 9 polymorphisms influence mother-to-child transmission of human immunodeficiency virus type 1. J Transl Med 2010, 8:49.
29. Cartegni L., Chew S.L., Krainer A.R. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 2002, 3:285-298.
30. Pagani F., Baralle F.E. Genomic variants in exons and introns: identifying the splicing spoilers. Nat Rev Genet 2004, 5:389-396.
31. Brest P., Lapaquette P., Souidi M., Lebrigand K., Cesaro A., Vouret-Craviari V., et al. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nat Genet 2011, 43:242-245.
32. Duan J., Wainwright M.S., Comeron J.M., Saitou N., Sanders A.R., Gelernter J., Gejman P.V. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 2003, 12:205-216.
33. Kudla G., Murray A.W., Tollervey D., Plotkin J.B. Coding-sequence determinants of gene expression in Escherichia coli. Science 2009, 324:255-258.
34. Sauna Z.E., Kimchi-Sarfaty C. Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet 2011, 12:683-691.
35. Nassetta L., Kimberlin D., Whitley R. Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies. J Antimicrob Chemother 2009, 63:862-867.